Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Current Opinion in HIV and AIDS|July 23, 2013
New clinical trial designs for HIV vaccine evaluationZoe Moodie, Holly Janes, Yunda HuangLifetime Data Analysis|September 1, 2005
An adjustment to improve the bivariate survivor function repaired NPMLEF Zoe Moodie, Ross L PrenticElectronic Journal of Statistics|November 17, 2023
Improved inference for vaccine-induced immune responses via shape-constrained methodsNilanjana Laha, Zoe Moodie, Ying Huang, et al.Methods in Molecular Biology (Clifton, N.J.)|September 30, 2011
Response determination criteria for ELISPOT: toward a standard that can be applied across laboratoriesZoe Moodie, Leah Price, Sylvia Janetzki, et al.Statistics in Medicine|July 6, 2012
Comparing and combining data across multiple sources via integration of paired-sample data to correct for measurement errorYunda Huang, Ying Huang, Zoe Moodie, et al.Statistics in Medicine|April 2, 2026
Comparing HIV Vaccine Immunogenicity Across Trials With Different Populations and Study DesignsYutong Jin, Alex Luedtke, Zoe Moodie, et al.Journal of Immunological Methods|September 9, 2006
Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trialsZoe Moodie, Yunda Huang, Lin Gu, et al.Contemporary Clinical Trials|June 22, 2024
The time-dependent Poisson-gamma model in practice: Recruitment forecasting in HIV trialsArmando Turchetta, Erica E M Moodie, David A Stephens, et al.BMC Medical Research Methodology|June 24, 2023
Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with disciplineFatima Laher, Mookho Malahleha, Shelly Ramirez, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshopDean Follmann, Ann Duerr, Stephen Tabet, et al.Pageof 8